Another study showed that the level of plasma protein disulfide-isomerase A6 (PDIA6) was downregulated in patients with PDA; it may have potential clinical implications for PDA treatment and provide evidence regarding the etiology and molecular mechanism of PDA [93]. The gene discussed is PDIA6; the disease is Patent ductus arteriosus.